Huang Y - Search Results

1

Identification of a cancer associated fibroblasts-related index to predict prognosis and immune landscape in ovarian cancer.

Ye Y, Zhang S, Jiang Y, Huang Y, Wang G, Zhang M, Gui Z, Wu Y, Bian G, Li P, Zhang M. Ye Y, et al. Among authors: huang y. Sci Rep. 2023 Dec 7;13(1):21565. doi: 10.1038/s41598-023-48653-w. Sci Rep. 2023. PMID: 38057405 Free PMC article.

2

Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma.

Ye Y, Zhao Q, Wu Y, Wang G, Huang Y, Sun W, Zhang M. Ye Y, et al. Among authors: huang y. Front Genet. 2022 Sep 23;13:989719. doi: 10.3389/fgene.2022.989719. eCollection 2022. Front Genet. 2022. PMID: 36212154 Free PMC article.

3

Identification and validation of a novel anoikis-related long non-coding RNA signature for pancreatic adenocarcinoma to predict the prognosis and immune response.

Jiang Y, Ye Y, Huang Y, Wu Y, Wang G, Gui Z, Zhang M, Zhang M. Jiang Y, et al. Among authors: huang y. J Cancer Res Clin Oncol. 2023 Nov;149(16):15069-15083. doi: 10.1007/s00432-023-05285-x. Epub 2023 Aug 24. J Cancer Res Clin Oncol. 2023. PMID: 37620430

4

Huang Y, Gong P, Su L, Zhang M. Huang Y, et al. Sci Rep. 2023 Nov 27;13(1):20870. doi: 10.1038/s41598-023-47223-4. Sci Rep. 2023. PMID: 38012210 Free PMC article.

5

Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis.

Ye Y, Jiang H, Wu Y, Wang G, Huang Y, Sun W, Zhang M. Ye Y, et al. Among authors: huang y. Front Mol Biosci. 2022 Sep 23;9:1001225. doi: 10.3389/fmolb.2022.1001225. eCollection 2022. Front Mol Biosci. 2022. PMID: 36213111 Free PMC article.

6

Effectiveness and safety of mono-anlotinib mono therapy or in combination with chemotherapy in platinum-resistant recurrent ovarian cancer: a single-center retrospective study.

Wu Y, Li P, Zhu Y, Zhang F, Su L, Ye Y, Huang Y, Zhang M. Wu Y, et al. Among authors: huang y. Am J Transl Res. 2023 Mar 15;15(3):1973-1981. eCollection 2023. Am J Transl Res. 2023. PMID: 37056822 Free PMC article.

7

Construction of a novel cancer-associated fibroblast-related signature to predict clinical outcome and immune response in colon adenocarcinoma.

Zheng L, Zhang J, Ye Y, Shi Z, Huang Y, Zhang M, Gui Z, Li P, Qin H, Sun W, Zhang M. Zheng L, et al. Among authors: huang y. Aging (Albany NY). 2023 Sep 16;15(18):9521-9543. doi: 10.18632/aging.205032. Epub 2023 Sep 16. Aging (Albany NY). 2023. PMID: 37724904 Free PMC article.

8

Isocitrate dehydrogenase 1 mutation in cholangiocarcinoma impairs tumor progression by sensitizing cells to ferroptosis.

Su L, Huang Y, Zheng L, Zhu Z, Wu Y, Li P. Su L, et al. Among authors: huang y. Open Med (Wars). 2022 May 6;17(1):863-870. doi: 10.1515/med-2022-0477. eCollection 2022. Open Med (Wars). 2022. PMID: 35600114 Free PMC article.

9

Application of robotic single-site surgery with optional additional port for endometriosis: a single institution's experience.

Huang Y, Duan K, Koythong T, Patil NM, Fan D, Liu J, Guan Z, Guan X. Huang Y, et al. J Robot Surg. 2022 Feb;16(1):127-135. doi: 10.1007/s11701-021-01217-4. Epub 2021 Mar 2. J Robot Surg. 2022. PMID: 33651315

10

A minimalist multifunctional nano-prodrug for drug resistance reverse and integration with PD-L1 mAb for enhanced immunotherapy of hepatocellular carcinoma.

Zou T, Huang Y, Zhou Z, He S, Liu J, Chen Y, Liu H, Luo Z, Liu M, Wei H, Yu C. Zou T, et al. Among authors: huang y. J Nanobiotechnology. 2024 Dec 3;22(1):750. doi: 10.1186/s12951-024-03027-w. J Nanobiotechnology. 2024. PMID: 39627819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80,956 results

Search Page

Filters